Are IBB and SCHX in the same category?

IBB is a thematic ETF and SCHX is a stock ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.

Which returned more over the last year, IBB or SCHX?

In the year to Oct 28, 2026, with distributions reinvested, IBB returned +37.5% and SCHX +13.1%.

Which is cheaper, IBB or SCHX?

SCHX is cheaper, by 0.41 percentage points a year. That is about $41 on $10,000 held for a year. Fees come from each fund's prospectus.

How much do IBB and SCHX overlap with the S&P 500?

By their latest filed holdings, 40% of IBB and 94% of SCHX by weight is stocks the S&P 500 already holds.

Data as of Oct 28, 2026.

Across categories

IBB vs SCHX: Differences, Returns & Fees

Share on X Download as PDF

Over the year to Oct 28, 2026, IBB returned +37.5% to SCHX's +13.1%, and SCHX charges 0.03% to IBB's 0.44%.

askIQ about this page

askIQ about IBB and SCHX

Net assets: $11.0bn on Oct 27, 2026 for iShares Biotechnology ETF, and $74.2bn on Aug 31, 2026 for Schwab U.S. Large-Cap ETF.

IBB on its own →SCHX on its own →

At a glance

+37.5%

IBB total return, 1 year

+13.1%

SCHX total return, 1 year

0.44%

IBB expense ratio

0.03%

SCHX expense ratio

Pair scorecard

SCHX costs 0.41 points a year less; their one-year returns differ by 24.4 points.

IBB vs SCHX: Differences, Returns & Fees
Measure	IBB	SCHX
Return
Measure	IBB	SCHX
Total return, 1 year	+37.5%	+13.1%
Benchmark
Measure	IBB	SCHX
What it tracks	Biotech	Dow Jones U.S. Large-Cap Total Stock Market Index
Cost and size
Measure	IBB	SCHX
Expense ratio	0.44%	0.03%
Net assets, IBB as of Oct 27, 2026 and SCHX as of Aug 31, 2026	$11.0bn	$74.2bn
Active share vs the S&P 500	99%
Holdings
Measure	IBB	SCHX
Holdings in common	1%
Top ten holdings, share of the fund	50%	36.0%

Holdings in common uses holdings dated Aug 31, 2026 and Oct 27, 2026. Method

What they share

By the books each fund has filed, IBB and SCHX hold 1% of their money in the same securities at the same weight. Holdings dated Aug 31, 2026 and Oct 27, 2026.

50%

0 half 100%

half

1% in common

Positions both hold · largest shared weight first IBB SCHX

AMGEN INC 8.20% 0.33%

GILEAD SCIENCES 8.56% 0.26%

VERTEX PHARMACEUTICALS 7.53% 0.20%

REGENERON PHARMACEUTICALS 5.64% 0.12%

MODERNA 5.29% 0.07%

NATERA 3.85% 0.07%

ILLUMINA INC 2.93% 0.05%

ALNYLAM PHARMACEUTICALS 2.11% 0.05%

BIOGEN 2.58% 0.05%

INSMED 1.42% 0.04%

UNITED THERAPEUTICS 1.71% 0.03%

INCYTE CORP 1.63% 0.03%

Only in one fund ↓

Only in IBB

ARGENX SE ADR 3.42%

REVOLUTION MEDICINES 2.50%

BEONE MEDICINES AG 2.15%

GENMAB SPONSORED ADR 1.72%

CHARLES RIVER LABORATORIES INTERNA 1.18%

ASCENDIS PHARMA 1.06%

HALOZYME THERAPEUTICS 1.01%

BRIDGEBIO PHARMA 0.85%

Only in SCHX

NVIDIA Corp 7.69%

Apple Inc 6.69%

Microsoft Corp 5.42%

Amazon.com Inc 3.66%

Alphabet Inc 2.86%

Broadcom Inc 2.52%

Alphabet Inc 2.28%

Meta Platforms Inc 1.81%

Check overlap with more funds →

Side by side

IBB iShares Biotechnology ETF SCHX Schwab U.S. Large-Cap ETF

Where it sits Thematic ETF Stock ETF

Issuer iShares Schwab

What it is Biotech Tracks an index of U.S. Large-Cap

Total return, 1 year +37.5% +13.1%

Its benchmark over the same days not measured +13.7% (IVV)

Gap to its benchmark not measured −0.6 pts vs IVV

Expense ratio 0.44% 0.03%

Already in the S&P 500 40.2% 93.6%

Holdings 245 747

Net assets, IBB as of Oct 27, 2026 and SCHX as of Aug 31, 2026 $11.0bn $74.2bn

IBB and SCHX on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

About each fund

IBB

By weight, 40% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 50% of the fund across 245 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +37.5% with distributions reinvested.

SCHX

SCHX tracks an index of U.S. Large-Cap. Over the year to Oct 28, 2026 it returned +13.1% with distributions reinvested, against +13.7% for its benchmark, the S&P 500 Index. The prospectus expense ratio is 0.03% a year. By its holdings filed for Aug 31, 2026, 94% of the fund by weight is stocks the S&P 500 also holds, across 747 positions, with the top ten at 36.0%.

Questions people ask

Are IBB and SCHX in the same category?: IBB is a thematic ETF and SCHX is a stock ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, IBB or SCHX?: In the year to Oct 28, 2026, with distributions reinvested, IBB returned +37.5% and SCHX +13.1%.
Which is cheaper, IBB or SCHX?: SCHX is cheaper, by 0.41 percentage points a year. That is about $41 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do IBB and SCHX overlap with the S&P 500?: By their latest filed holdings, 40% of IBB and 94% of SCHX by weight is stocks the S&P 500 already holds.

Other comparisons

IBB vs SPYM IBB vs XLG IBB vs IVV GRNY vs IBB SCHX vs XBI AIRR vs SCHX GDX vs SCHX LYTE vs SCHX

Where to next

IBB on its own →SCHX on its own →Hold both: look the portfolio through →Rankings →IBB dividend history →IBB holdings →SCHX dividend history →SCHX holdings →Standards and sources →

Sources and dates

IBB filings on SEC EDGAR ↗

IBB prospectus with the expense ratio (SEC) ↗

iShares page for IBB ↗

SCHX filings on SEC EDGAR ↗

SCHX prospectus with the expense ratio (SEC) ↗

Schwab website ↗

Links are sources, not endorsements. A comparison is not a recommendation.

How this is computed

Overlap adds up the smaller of the two weights for each security both funds hold.

Cite this pageCitation, APA and Markdown

ETFIQ, IBB against SCHX, data as of Oct 28, 2026. https://etfiq.com/compare/any/ibb-vs-schx

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.